Clínica Baviera, S.A. (BME:CBAV)
57.20
-1.20 (-2.05%)
Jul 17, 2026, 5:35 PM CET
Clínica Baviera Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.59 | 10.14 | 8.31 | 19.17 | 9.8 |
Short-Term Investments | - | - | 42.93 | 19.82 | 22.47 |
Cash & Short-Term Investments | 5.59 | 10.14 | 51.24 | 38.99 | 32.27 |
Cash Growth | -44.88% | -80.21% | 31.42% | 20.82% | 19.81% |
Accounts Receivable | - | - | 3.01 | 3.15 | 3.45 |
Other Receivables | 0.1 | 0.54 | - | 0.31 | 0.03 |
Total Trade Receivables | 0.1 | 0.54 | 3.01 | 3.46 | 3.48 |
Inventory | 3.33 | 3.28 | 2.47 | 2.16 | 1.93 |
Other Current Assets | 0.86 | 1.3 | 1.01 | 0.31 | 0.32 |
Total Current Assets | 59.34 | 47.98 | 57.74 | 44.61 | 37.92 |
Net Property, Plant & Equipment | 142.48 | 122.66 | 99.06 | 86.08 | 77.25 |
Other Intangible Assets | 11.08 | 8.73 | 2.75 | 0.46 | 1 |
Goodwill | 29.01 | 28.31 | 14.62 | 14.62 | 14.62 |
Long-Term Investments | 0.1 | 0.06 | 3.07 | 3.33 | 2.04 |
Other Long-Term Assets | 3.16 | 1.88 | 1.4 | 1.01 | 0.98 |
Total Assets | 247.51 | 211.95 | 178.64 | 150.1 | 133.81 |
Accounts Payable | 13.01 | 10.06 | 15.52 | 27.65 | 23.74 |
Accrued Expenses | 9.5 | 7.61 | 2.07 | 5.83 | 5.3 |
Current Portion of Long-Term Debt | 2.04 | 1.91 | - | 18.99 | 20.54 |
Current Portion of Leases | 24.39 | 20.72 | 17.96 | 14.98 | 12.34 |
Other Current Liabilities | 12.53 | 10.4 | 3.83 | 8.28 | 6.37 |
Total Current Liabilities | 61.47 | 50.7 | 45.27 | 41.04 | 35.87 |
Long-Term Debt | 5.89 | 5.29 | - | 40.49 | 46.36 |
Long-Term Leases | 61.82 | 51.49 | - | 35.46 | 33.42 |
Other Long-Term Liabilities | 7.37 | 6.11 | 40.6 | 2.72 | 2.66 |
Total Long-Term Liabilities | 75.09 | 62.89 | 41.1 | 40.7 | 42.55 |
Total Liabilities | 136.55 | 113.59 | 86.37 | 81.73 | 78.41 |
Common Stock | 1.63 | 1.63 | 1.63 | 3.26 | 3.26 |
Treasury Stock | -8.42 | -9.14 | -0.11 | -0.09 | -0.08 |
Additional Paid-in Capital | 5.97 | 5.4 | 4.89 | 4.89 | 4.89 |
Accumulated Other Comprehensive Income | 1.05 | 0.56 | - | 0.1 | 0.07 |
Retained Earnings | 109.77 | 98.47 | 83.7 | 60.81 | 48.09 |
Total Common Shareholders' Equity | 218.93 | 193.29 | 91 | 134.59 | 109.14 |
Minority Interest | 0.97 | 1.44 | 1.28 | 1.02 | 0.79 |
Shareholders' Equity | 110.96 | 98.36 | 92.28 | 68.37 | 55.4 |
Total Liabilities & Equity | 247.51 | 211.95 | 178.64 | 150.1 | 133.81 |
Total Debt | 94.13 | 79.41 | 17.96 | 109.92 | 112.66 |
Net Cash (Debt) | -88.54 | -69.27 | 33.28 | -70.93 | -80.39 |
Net Cash Per Share | -5.53 | -4.33 | 2.04 | -4.35 | -4.93 |
Book Value | 218.93 | 193.29 | 91 | 134.59 | 109.14 |
Book Value Per Share | 13.67 | 12.08 | 5.58 | 8.26 | 6.69 |
Tangible Book Value | 178.84 | 156.25 | 73.63 | 119.51 | 93.53 |
Tangible Book Value Per Share | 11.17 | 9.76 | 4.52 | 7.33 | 5.74 |